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1. Introduction 
Pacemakers may cause undesirable complications during and after implantation.  
Complications associated with the implantation procedure are uncommon, but include 
bleeding, infection, or collapsed lung. Generally, each of these problems can be treated quite 
effectively. Though rare, pacemaker problems can occur long after the implantation 
procedure. These "late" complications include generator failure (extremely rare), and lead 
failure (less rare). Most of these complications are uncommon, and can be prevented by 
simple manoeuvres. Nonetheless, there are some complications related to pacemaker system 
disfunctions which may cause life-threatening complications. Pacemaker malfunctions may 
be corrected with accurate, timely diagnosis, but will not be discussed in this chapter.   
Pacemaker complications can be divided into acute (immediate) or chronic according to 
implantation time (or date); lead or pocket complications according to the site of 
complication; and implantation or system failures, according to aethiology (Table 1). The 
most common and frequent complications are those related to implantation. Pacemaker 
implantation is a safe procedure in experienced hands, but these complications can be 
caused even by experienced operators. By following the suggested maintenance schedule, 
physicians usually detect pacemaker problems before they become serious. However, it 
remains important for patients to be aware of the symptoms of bradycardia, symptoms that 
might indicate a pacemaker malfunction. Once again, these symptoms include weakness, 
easy fatigability, lightheadedness, dizziness, and loss of consciousness. Patients 
experiencing any of these symptoms should notify their doctor. Especially following 
complications such as lead dislodgment, pnemothorax, lead indection, and cardiac 
tamponade, the patients must be informed about these symptoms. 
The frequency of complications varies between 10% and 59% for the procedures. This wide 
range exists due to the common problem of defining complications. In some papers, a 
localized infection or rib fracture is defined as a minor complication. However, in other 
papers, these complications are not even recorded. If the pacemaker lead becomes dislodged 
on day 4, is this a complication or not? Some authors say yes; others no. This ambiguity 
leads to a great challenge when trying to compare papers. In this chapter, we will try to 
discuss these problems systematically and transparently.  
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Significant reductions in frequency of complications related to pacemakers have been noted 
due to emerging technological developments, ever increasing experience and patient 
education. 
 
Complications 
Pocket complications Lead complications 
Pocket hematoma Acute perforation 
İnfection  Dislodgement 
Erosion  Infection 
Migration of pacemaker Vein thrombosis 
Twiddler’s syndrome Migration 
Table 1. Classification of pacemaker complications.  
2. Complications related to the implantation procedure 
Several lead-related complications deserve attention, including lead dislodgement, 
pneumothorax, loose connector pin, conductor coil (lead) fracture, and insulation break. 
2.1 Lead dislodgement 
Pacing lead displacement and dislodgement is a relatively common problem and can occur 
in 5-10 % of the patients (National Pacemaker and ICD database, 2001). Historically, the 
most common complication of transvenous pacing has been lead dislodgement. The leads 
can displace within chambers or out of chambers and should be suspected if the wire 
appears too taut or too redundant. Leads may dislodge from the initial implant site in the 
first few days to few weeks following the implantation. Active and passive fixation 
mechanism of leads help prevent this complication. Atrial lead dislogement is slightly more 
common than it is for venrricular leads. Acceptable dislodgmenet rates should be probably 
be less than 1% for ventricular leads and no more than 2-3% for atrial leads (Braunwald). 
Although passive fixation leads are stable in the atrial appendage, active fixation leads are 
necessary to prevent dislodgement in patients with prior cardiac surgery. Lead 
dislodgement may result in an increase in pacing thresholds, failure to capture, or failure to 
sense. Lead dislodgement may be radiographically visible or it may be microdislodgement, 
where there is no radiographic change in position, but there is significant increase in pacing 
threshold and/or decline in the electrocardiogram amplitude (Figure 1). Also migration of a 
dislodged lead out of the heart may be associated with thromboembolic complications if it is 
not detected acutely.  
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Fig. 1. Top (A): Postero-anterior and lateral chest X-ray films obtained 24 hours after 
pacemaker implantation showing atrial lead tip (arrow head) inside the right atrial 
appendage; Bottom (B): Radiograph obtained three months later showing displacement of 
atrial lead (arrow head) towards tricuspid annulus. 
2.2 Pneumothorax, hemothorax, and air embolism 
This complication occurs uncommonly and is directly related to operator experience, the 
difficulty of the subclavian vein puncture, and is almost eliminated using the cephalic cut-
down technique. The incidence of pneumothorax ranges from 1.6 to 2.6 % with 80 % of 
thesecases requiring chest tube placement if > 10 % of the lung is involved, the patient has 
continued repiratory distress, or hemo-pneumothorax is present (Grier et al., 1990). A 
pneumothorax estimated to involve < 10 % of the pleural space can probably be observed 
without chest tube placement. This can occur from inadvertent puncture and laceration of 
the subclavian vein or the subclavian artery or the lung.  
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If a pneumothorax develops, it may manifest during the pacemaker procedure or as late as 
48 hours after implantation (Figure 2). However, these traditional comparisons may become 
obsolete as the axillary vein cannulation technique (Martin et al., 1996) threatens to eliminate 
this controversery. To minimize the risk of pneumothorax, fluoroscopic guidance of the 
subclavian puncture should be used together with careful technique, or to use safe sheats 
with one-way mechanism which also reduces risk of other potential complications 
(hemothorax, inadvertent arterial puncture, air embolism, arteriovenous fstula, thoracic duct 
injury, and brachial plexus injury). Often pneumothorax is asymptomatic and noted on 
routine follow-up plain chest radiograph.  
 
 
Fig. 2. Chest X-ray showing right pneumothorax (arrow) 8 h after placement of a left-sided 
permanent dual chamber pacemaker. 
Location of pneumothorax, i.e. ipsilateral or contralateral was reported. Contralateral 
pneumothorax to the site of the pacing system has been reported, which was secondary to 
an unsuccessful attempt on that side (Sebastian et al., 2005).  
In the setting of pneumothorax, pneumopericardium can occur when air dissects through 
the pulmonary parenchyma along the perivascular sheats back to the hilum. The 
pericardium is weakest at its reflection surrounding the ostia of the pulmonary veins and air 
can leak into the pericardial space at this location. In haemodynamically stable patients, CT 
scan of the chest is investigation of choice (Figure 3). In unstable patients emergency 
echocardiography may be useful to identify pericardial effusion (Burney et al., 2004). 
Deep inspiration at the time of central venous access may cause significant air to be drawn 
into the venous system due to the physiological negative pressure developed. Three 
obligatory conditions need to coexist for pulmonary air embolism to occur: (1) there must be 
a source of gas/air; (2) an open access to the venous system; and (3) a pressure gradient 
between the source of gas/air and the venous sytem (Yeakel, 1968). It can be prevented 
through operator care and using introducers with hemostatic valves. The diagnosis is 
obvious because it is heralded by a hissing sound as the air is sucked in and with the 
fluoroscopic confirmation that follows (Figure 4). 100% oxygen should be administered 
along with ionotropic support in some cases. Aspiration of the embolus from the right heart 
has also been successful. However, usually no therapy is required, as the air is filtered and 
consequently absorbed in the lungs. 
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Fig. 3. CT scan of the chest showing massive hemothorax, pneumothorax, and 
pneumopericardium.  
 
 
Fig. 4. Chest X-ray showing a large air embolus (arrow) in the main pulmonary artery 
bifurcation during permanent pacemaker implantation.  
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Three main issues are important in diagnosis and management of this problem: (1) deep 
inspiration should be avoided in the presence of an open intravenous route; (2) when using 
a peal-away sheath, temporarily close the intravenous entrance route before inserting the 
lead; and (3) snoring may be an alarm sound! (Turgeman et al., 2004).  
2.3 Lead perforation 
Myocardial perforation during lead placement is an uncommon but potentially serious 
complication. The published incidence of this complication varies from 0.4 to 5.2%, but 
nowadays it is usually lower than 1% (Danik et al., 2007; Carlson at al., 2008). The use of 
active fixation leads is associated with higher rate of cardiac perforations (Geyfman et al., 
2007). Recently, several reports on increased rate of cardiac perforations with both active 
and passive defibrillation leads of one model have published (Satpathy et al., 2008). 
The definition of a subacute and delayed myocardial perforation is normal X-ray and 
electrical parameteres (R-wave sensing, pacing threshold, impedance) 24 hours after 
implantation without clinical signs of perforation and the diagnosis of lead perforation by X-
ray (Figure 5), echocardiography, or computed tomography 5 days to 1 month (subacute) or 
≥ 1 month (delayed) after implantation. Delayed lead perforation (occuring more than 1 
month after implantation) is a rare complication. Its pathophysiology and optimal 
management are currently unclear. Delayed lead perforations are fewer in number than 
acute lead perforations in the literature (Velavan et al., 2003; Khan et al., 2005). Delayed lead 
perforations have caused chest pain, hemopneumothorax and pneumothorax, but no cases 
of cardiac tamponade or death have been documented (Trigano & Caus, 1996). One of the 
distinguishing features of delayed lead perforation as opposed to acute lead perforation is 
the decrease or absence of cardiac tamponade or death.  
 
 
Fig. 5. Chest X-ray demonstrating severe lead perforation due to implantable cardioverter-
defibrillator implantation. 
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Surprisingly, the perforation rate did not differ significantly between the pacemaker and 
ICD implantation. Hirschl et al. found that atrial leads perforated more frequently than 
ventricular leads, and ICD leads perforate more frequently than ventricular pacemaker 
leads (Hirschl et al., 2007). The factors that may influence the perforation ratio rate could be 
divided into three groups: 
1. Lead design (diameter, fixation mechanism, construction of the lead tip, pre-shaped J-
curve), 
2. Physicians’ experience and training level, 
3. Patient-related factors 
Clinical presentations of late perforation may vary widely from asymptomatic patients to 
sudden cardiac death. This highlights the importance of a high degree of suspicion and the 
need of proper diagnostic methods. Diagnosis of a perforation is usually based on clinical 
findings. Echocardiographic imaging may suggest perforation, but unless the lead is 
completely through the myocardium, the study may be inconclusive. More recently, CT has 
been reported as a method of diagnosing myocardial perforation (Figure 6). Diagnosis of 
perforation is made using four signs: 
1. Decrease in arterial blood pressure without any other explanation, 
2. Decrease in pulsatility of the cardiac silhouette as monitored by fluoroscopy, 
3. Increased size of the cardiac silhouette, 
4. Abnormal position of the transvenous lead too far out toward the left ventricle along 
the pericardial outline 
 
 
Fig. 6. CT images of the thorax emonstrating right ventricular (RV) lead position and cardiac 
perforation by RV electrode. 
Currently, approprate management of lead perfroration is uncertain. Perforation associated 
with hemodynamic compromise must be dealt with as an emergency. The lead may 
perforate any of the great veins, the atria, or ventricle during the implant procedure. This 
complication almost always occurs in the cardiac chamber on lead manipulation or fixing a 
screw in lead, and consequently bleeds into the pericardial space. A most devastating 
manifestation is cardiac tamponade, which requires prompt diagnosis and percutaneous 
pericardiocentesis, possibly followed by surgical intervention if the bleeding persists. 
Rarely, trauma to the great veins above the pericardial reflection may cause bleeding 
directly into the mediastinum. This is much more of a concern when extracting leads than 
implanting them and is an emergent indication for open chest surgery. Furhermore, the 
management described in the literature depends on the lead type. 
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Another late complication of lead perforation occurs at the time of lead extraction if 
required. While active fixation leads have mostly been extracted transvenously after 
retraction of the coil, extraction of passive fixaton leads causes concern because of the bulky 
tip of the lead may cause tissue damage during removal. Khan and colleagues recommend 
that lead extraction should be done in the operating room under TEE observation with 
cardiac surgery backup (Khan et al., 2005). 
Overall, our experience with delayed lead perforations with lead perforations has provided 
a management scheme as outlined above that incorporates clinical history, chest X-ray, and 
device interrogation among other diagnostic tools (echocardiography, CT etc.).  
2.4 Extracardiac stimulation 
Extracardiac stimulation usually involves the diaphragm or pectoral or intercostal muscles. 
Diaphragmatic stimulation may be caused by direct stimulation of the diaphragm (usually 
stimulation of the left hemidiaphragm) or stimulation of the phrenic nerve (usually 
stimulation of the right hemidiaphragm). Diaphragmatic stimulation occuring during the 
early postimplantation period may be caused by microdislodgment of the pacing lead. This 
phenomenon is most commonly in patients with LV coronary vein branch lead placement 
for biventricular stimulation. During implant, high-output pacing at maximal voltage and 
pulse width should be tested routinely to avoid diaphragmatic stimulation. Stimulation can 
be minimized or alleviated by decreasing the voltage output or pulse width, or both, but an 
adequate pacing margin of safety must be maintained after the output parameters are 
decreased. If the problem cannot be resolved by reprogramming the pacemaker output, lead 
repositioning will be required at the moment.  
Pectoral stimulation may be due to incorrect orientation of the pacemaker with its active 
surface in contrast with the muscle or a current leak from a lead insulation failure or 
exposed connector. 
2.5 Venous thrombosis and superior vena cava syndrome (SVCS) 
Venous thrombosis occurs early or late after pacemaker implantation in 30% to 50% of 
patients and may remain asymptomatic because of the development of venous collaterals 
(Oginosawa et al., 2002). Manifestations vary from usually asymptomatic, acute 
symptomatic thrombosis, and even SVCS (Mazzetti et al., 1993). Venous complications of 
pacemaker/ICD system implantation rarely cause immediate clinical problem. Only a few 
percent (1-3%) of patients with severe stenosis or occlusion of the deep veins of an upper 
extremity become symptomatic (Stoney et al., 1976; Crook et al., 1977).  
A few factors were proposed as predictors of severe venous stenosis/occlusion: a) presence 
of multiple pacemaker leads (compared to a single lead), b) use of hormone therapy, c) 
personal history of venous thrombosis, d) the presence of temporary wire before 
implantation, e) previous presence of a pacemaker (ICD as an upgrade) and f) the use of 
dual-coil leads. The presence of arm swelling, collateral veins on the arm, thorax or 
abdomen and possible associated facial suffision, cyanosis or edema with head and neck 
discomfort are classical symptoms. Routine preoperative venography to detect has been 
advocated before all device lead revision cases, so as alternative access can be considered 
(Spittell & Hayes, 1992).  
Different management approaches should be used, depending on the time since onset of 
stenosis/thrombosis, its location, and the presence of symptoms. Asymptomatic patients are 
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usually not treated because their disease is silent and often undetected. Symptomatic 
patients who develop venous thrombosis should be treated promptly. Specific treatment 
depends on thrombosis or fibrosis being causative and varies from heparin followed by 
warfarin or thrombolysis to percutaneous angioplasty or an open surgical procedure. 
Surgery is always the last resort, reserved for patients with symptomatic occlusions that do 
not respond to treatment with anticoagulation or have contraindications to endovascular 
procedure (Rozmus et al., 2005). 
A rare associated complication is pulmonary thromboembolism that is potentially life-
threatening. The presence of pulmonary embolism in a patient with a device should be 
arouse the suspicion of thromboic pacemaker (or ICD) lead source (Phibbs & Marriott, 1985). 
2.6 Twiddler syndrome 
Displacement of pacemaker leads due to twisting of the box on part of the patient is called 
Twiddler’s syndrome, first described in 1968 (Nicholson et al., 2003).Twiddler syndrome 
that causes device malfunction is a rare complication in patients with an implantable 
cardioverter defibrillators (ICD) (Fahraeus & Höijer, 2003). Twisting of the pulse generator 
within the device pocket may cause the dislocation of the lead, diaphragmatic stimulation, 
and loss of capture (Figure 7). The prevelance of this syndrome is 0.07% (Gungor et al., 
2009). Classically, Twiddler syndrome occurs in obese women with loose, fatty 
subcutaneous tissue and is characterized by rotation of pulse generator on its long axis with 
subsequent coiling of pacemaker leads (Bhatia et al., 2007). Other risk factors are mental 
disorders, female sex, and the small size of the implanted generator with a large pocket 
(Cardall et al., 1999). This disorder may induce lead dislodgement or lead fracture and cause 
life-threatening symptoms in case of pacemaker dependency. When the pulse generator is 
rotated along the transverse axis it is referred by us as the Reel sundrome, a variant of 
Twiddler syndrome (Camero-Varo et al., 1990).  
 
 
Fig. 7. Pacemaker Twiddler syndrome. Postero-anterior and lateral chest X-ray showing 
displacement of both leads, especially the ventricle one, retracted and floating in the right 
atrium (arrows).  
In Twiddler syndrome, electrocardiography shows failure of capture and the chest 
radiography reveals the dislodged and twisted leads (Pereira et al., 1999). Hypoperfusion 
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symptoms such as fatigue, tiredness, confusion, presyncope, and syncope may be observed 
(Cardall et al., 1999). If the problem has occured because of pacemaker migration or poorly 
fashioned pacemaker pocket, the pocket should be revised. As an inappropriate ICD 
therapy may be proarrhythmic and may lead to sudden cardiac death, Twiddler syndrome 
should be considered in patients with ICD who had resistant ventricular arrhythmias and 
abdominal pulsation. To avoid this life-threatening complication of ICD implantation, we 
should take care to limit the pocket size, suture the device to the fascia, and instruct the 
patients not to manipulate their device pockets.  
2.7 Postpacemaker implant pericarditis 
Pericarditis is an uncommon but potentially serious complication following a pacing system 
implantation. Pericarditis has been reported as a complication of pacemaker implantation 
associated with the use of active- and passive-fixation leads (Greene et al., 1994). It appeared 
to occur significantly more often when active-fixation atrial leads were used, affecting 5% of 
implants in this study. Active-fixation atrial leads have lower early dislodgement rates and 
are easier to remove after chronic placement. However, because the atrial wall is thin, these 
leads may be more likely to perforate the myocardium and cause pericarditis. Perforation 
through the right ventricular wall is also possible though the wall thickness is greater than 
in the atrium, and thus presumably less likely to occur. Alternatively, traumatic 
inflammation extending from the lead screw and traversing through the myocardium to the 
pericardium is also possible mechanism (Sivakumaran et al., 2002). Patients developing 
pericarditis postpacemaker implantation should be followed closely due to the risk of 
cardiac tamponade. If there is no evidence of tamponade or symptomatic pericardial 
effusion, it is reasonable initially to treat the patient conservatively, i.e., observation and 
pain medications. Anti-inflaammatory medications, e.g., nonsteroidal or steroids, may 
relieve symptoms. However, if the medications cannot be withdrawn without symptom 
recurrence, it may be necessary to remove and reposition the leads.  
3. Pocket-related complications 
3.1 Pocket hematoma 
Hematomas occuring at the pacemaker pocket site can vary from a small ecchymosis to 
large and tense swelling (Figure 8). The risk of haematoma is increased in patients taking 
antithrombotic or anticoagulant drugs (Goldstein et al., 1998). Most small hematomas can be 
managed conservatively with cold compress and withdrawal of antiplatelet or 
antithrombotic agents. In patients requiring oral anticoagulants (warfarin), to take INR of 
about 2.0 at the time of implantation is safe (Belott & Reynolds, 2000). Unfractionated 
heparin or low-molecular-weight heparin are always discontinued prior to device implant 
and ideally avoided for a minimum of 24 hours post implantation. Administration of 
anticoagulants can be resumed within 48-72 h after implantation if there is no evidence of 
substantial hematoma formation. Occasionally, large hematomas that compromise the 
suture line or skin integrity may have to be surgically evacuated. Evacuation of the 
hematoma is very rarely needed (<0.5% of cases). Needle aspiration increases risk of 
infection and should not be done. Aspiration should be considered only if there is continued 
bleeding, potential compromise of the suture line or skin integrity, or pain refractory 
analgesics (Pavia & Wilkoff, 2001).  
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Fig. 8. Pocket hematoma 
In patients who require therapeutic anticoagulation, heparin should be delayed for at least 
24 to 48 hours after implantation to avoid bleeding complications.  
3.2 Wound pain 
Patients should be told to expect some local discomfort at the pacemaker implantation site. 
For several reasons, a patient could experience a painful pacemaker site, commonly called 
‘’painful pocket’’, and the complaint should be taken seriously. The diferential diagnosis 
includes: 
• Infection  
• Pacemaker implanted too superficially 
• Pacemaker implanted too laterally 
• Pacemaker allergy 
Minor wound pain is expected after device implantation, almost always controlled with 
simple analgesia. In general, the pre-pectoral site is extremely well-tolerated, i.e., the 
pacemaker pocket should be formed in the prepectoralis fascia. If it is placed anterior to the 
adipose layer, i.e., within subcutaneous tissues, significant pain may result. If the pacemaker 
is positioned too laterally, impingement on the axillary space may cause discomfort. 
Continuing pain will usually improve or manifest an obvious infection eventually. 
However, pain that initially improves then recurs or occurs temporarily remote from the 
implant may suggest infection even in the absence of any outward localizing signs, and 
consequently may necessitate surgical exploration or even empirical removal and reimplant 
at another site. If a painful pocket is explored for any reason, specimens for culture should 
be obtained.  
3.3 Skin erosion  
Skin erosion is caused by the underlying pacemaker generator has been reported several 
times as a complication of pacemaker implants (Kiviniemi et al., 1999). This is the most 
common late complication of pacemaker implantation abd its incidence has been estimated 
around 0.8% (Harcombe et al., 1998).  
Factors predisposing skin erosion are the tissue fragility in old-age patients, the presence of 
a thin subcutaneous fat layer and abrasive action exerted on the skin from external agents 
(Figure 9). Other common causes of skin erosion are possible infections of the site and the 
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pressure exercised from the device on the subcutanous tissue (Harcombe et al., 1998). 
Griffith et al. concluded that if pacemaker erosion is not caused by infection it can be 
successfully managed by ipsilateral re-implantation, i.e., revision and this is a financially 
advantageous solution (Griffith et al., 1994). If true eroison occurs, the system is considered 
contaminated and current opinion favors removal of the generator and leads to the clean site 
(Shapiro et al., 2004; Guiseppe et al., 2009). It is crucial to identify early signs of erosion 
before the hardware breaks the skin. If the skin is intact, surgical revision of the pocket is 
often all that is needed to protect the hardware from contamination and infection.  
  
 
Fig. 9. Erosion of the automated implantable cardioverter-defibrillator (AICD).  
3.4 Allergic reactions to the pacemaker component 
Pacemaker component allergy is a relatively uncommon cause of erithema and pain at the 
site of an implanted pacemaker. Diagnosis is often postponed and/or misinterpreted as a 
skin infection. Allergies to multiple pacemaker components have been well described 
(Hayes & Loesl, 2002). Most reactions occur between several weeks to a few months after 
implantation. The diagnosis should be suspected in cases of skin reaction following 
pacemaker implantation that does not respond promptly to antibiotic treatment. When 
infection has been ruled out, it may still be difficult to make a diagnosis of a pacemaker 
component allergy, for several reasons. Because a true allergic reaction to a pacemaker 
component is rare, the clinician may simply fail to include it in the differential diagnosis. 
Also, the allergy testing required is sophisticated and must be done correctly. Important, 
corticosteroid use can result in skin anergy and in a false-negative skin test.  
Allergies to various pacemaker components have been reported, including titanium (Peters 
et al., 1984; Yamauchi et al., 2000), polychloroparaxylene (Iguchi et al., 1997), nickel 
(Landwehr & van Ketel, 1983), polyurethane (Abdallah et al., 1994), epoxy (Andersen, 1979), 
mercury (Brun & Hunziker, 1980), cadmium (Laugier et al., 1975), chromate (Laugier et al., 
1975), silicone (Raque & Goldschmidt, 1970), and cobalt (Tilsey & Rotstein, 1980).  
Once an allergy has been demonstrated, it is imperative that the component either be 
eliminated from subsequent pacing systems or be completely coated. The only definitive 
treatment is removal of the allergens. Some patients may respond to topical corticosteroids 
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(Viraben et al., 1995). But replacement of the device for one that is free of allergenic 
components or wrapped with an inert coating is the treatmnet choice (Déry et al., 2002).  
3.5 Device-related infections  
Despite improvements in the design and implantation techiques, infection of the cardiac 
devices remain a serious problem. The first reports on infective complications after 
permanent endocardial stimulation were published in the 1960s. The reported incidence of 
pacemaker-related infection ranges from 0.5% to 6% in early series (Hill, 1987; Kearney et 
al., 1994). Recently, Uslan et al. reported the overall incidence of device-related infection to 
be 1.9 per 1000 device-years (Uslan et al., 2007). In the study by Aggarwal et al (Aggarwal et 
al., 1995), the incidence of infections in patients with dual-chamber (1%) compared with 
single-chamber devices (0.82 %) was similiar, whereas in the study by Chauan et al. (Chauan 
et al., 1994), wound infections developed in 0.6% of patients with single-chamber versus 
2.1% of patients with dual-chamber devices. This infection is associated with substantial 
morbidity, mortality, and financial cost (Sohail et al., 2007). The mortaility of persistent 
infection when infected leads are not removed can be as high as 66% (Rettig G, Doenecke et 
al. Complications with retained transvenous pacemaker electrodes. Am Heart J 1997; 98:587-
594). In a study by Sohail et al (Sohail et al., 2007) generator pocket infection (69%) and 
device-related endocarditis (23%) were the most common clinical presentations of infection.  
Several factors have been anecdotally reported (Eggimann et al., 2000) to be associated with 
an increased the risk of PPM infection, inckuding diabetes mellitus, malignancy, operator 
inexperience, advanced age, corticosteroid use, anticoagulation, recent device manipulation, 
chronic renal failure, and bacteremia from a distant focus of infection. Pacemaker 
endocarditis is most commonly complicated by tricuspid valve vegetations (Bortolotti et al., 
1993), tricuspid regurgitation, and occasionally by secondary pulmonary embolism (Klug et 
al., 1997). Also, the presence of multiple leads is a potential cause for central venous 
thrombosis, and has been thought to increase the risk of device infection by serving as a 
nidus for seeding of bacteria (Howarth et al., 1998). 
Device infection is defined as either: (a) deep infection - infection involving the generator 
pocket and/or the intravenous portion of the leads, with or without bacteremia, requiring 
device extraction or (b) superficial infection - characterized by local inflammation, involving 
the skin but not the generator pocket, and treated with oral antibiotics. Also Charles Byrd 
divided pacemaker-related infections into the following groups (Ellenbogen et al., 2007) 
• endocarditis; 
• inflammation of myocardial tissue; 
• infected vegetations; 
• infected implanted foreign bodies; 
• bacteremia without signs of endocarditis; 
• local infections of subcutaneous tissue; 
• chronic infections limited to the pocket area; 
• superinfection of pacemaker pocket area; 
• chronic pocket infection with granulation tissue 
Early infections are most commonly caused by Staphylococcus aureus and late infections 
most commonly by Staphylococcus epidermidis, although infections by Staphylococcus 
lugudensis (Anguera et al., 2005), streptococcus bovis, mitis, and sanguis, pseudomonas 
(Laguno et al., 1998), enterococci and fungi and even Mycobacterium fortuitum (Sharma et 
al., 2005) have been described (Figure 10).  
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Fig. 10. Microbiology of permanent pacemaker/ICD infections (With permission of: Sohail 
MR, Uslan DZ, Khan AH et al. Management and Outcome of Permanent Pacemaker and 
Implantable Cardioverter-Defibrillator Infections. J Am Coll Cardiol 2007; 49:1851-9).  
Pacemaker infection must be recognized and be treated properly. It may appaer as: 
• Local inflammation and abscess formation in the area of the pulse generator pocket 
• Erosion of part of the pacing system through the skin with secondary infection 
• Fever associated with positive blood cultures with or without a focus of infection 
elsewhere 
The most common clinical presentation is infection around the generator; septicemia is 
uncommon mode of presentation.  
There is general consensus that once there is pacemaker pocket or lead infection, removal of 
the whole pacemaker systme followed by a course of appropriate antibiotics results in the 
best prospect for long term eradication of infection. Antibiotic prophylaxis has been 
routinely prescribed to prevent the occurence of this complication; however, there is 
insufficient evidence that this strategy is benefical. In a study by de Oliveira et al (de 
Oliveira et al., 2009) found that antibiotic prophylaxis (single dose of 1 g of cefazolin) 
significantly reduces infectious complications in patinets undergoing pacemaker or 
cardioverter-defibrillators. When pacemaker lead or pocket infection is complicated by 
vegetations on the leads, heart valves or chamber endocardium or when there is secondary 
pulmonary embolism, removal of the entire device is more urgently indicated. The main 
recommendation is in favor of if there is vegetations that might obstruct main pulmonary 
artery should have removal under cardiopulmonary bypass (Tascini et al., 2006; Ruttman et 
al., 2006; Kaul et al., 2009).  
The duration of antimicrobial treatment for cardiac device infections (CDI) depended on the 
clinical presentation and the causative agent. In a large case series from the Cleveland Clinic 
Foundation (Chua et al., 2000), the median duration of antibiotic treatment in CDI cases 
with pocket infection and those with bacteremia was 26 days and 41 days, respectively. An 
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algorithm for management of the patient with an infected pacing or ICD system is shown in 
(Figure 11). This algorithm also demonstrates the timing and need of a replacement device. 
Guidelines suggested by Mayo Clinic for diagnosis and management of device infections are 
listed in (Table 2). 
 
 
Fig. 11. Mayo Clinic algorithm of cardiac device infection management. (A) Treatment 
algorithm based on blood and generator pocket cultures. This algorithm applies only to the 
patients with complete explanation of the implanted system. (B) Algorithm for 
reimplantation of new pulse generator. (With permission from Sohail MR, Uslan DZ, Khan 
AH, et al. Management and outcome of permanent pacemaker and implanted cardioverter-
defibrillator infections. JACC 2007; 49:1851-9). 
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1. All patients should have at least 2 sets of blood cultures drawn at initial evaluation. 
2. Generator tissue Gram stain and culture and lead tip culture should be obtained. 
3. Patients who either have positive blood cultures or have negative blood cultures but 
had recent antibiotics before obtaining blood cultures should have a transesophageal 
echocardiogram (TEE) to assess for device-related endocarditis. 
4. Sensitivity of TTE is low and is not recommended to evaluate for devvice-related 
endocarditis. 
5. Patients with negative blood cultures and recent prior antibiotics and valve 
vegetations on TEE should be managed in consultation with an infectious diseases 
expert. 
6. All patients with device infection should undergo complete device removal, 
regardless of clinical presentation. 
7. A large (>1 cm) lead vegetation is not a stand alone indication for surgical lead 
removal. 
8. Blood cultures should be repeated in all patients after device explantation. Patients 
with persistently positive blood cultures should be treated for at least 4 weeks with 
antimicrobial even if TEE is negative for vegetations or other evidence of infection. 
9. Duration of antimicrobial therapy should also be extended to ≥4 weeks in patients 
with complicated infection (endocarditis, septic venous thrombosis, osteomyelitis, 
metastatic seeding). 
10. Adequate debridement and control of infection should also be achieved at all sites 
before reimplantation of a new device. 
11. Reevaluation for continued need of the device should be performed before new 
device placement. 
12. If an infected cardiac device cannot be removed, than long-term suppressive 
antibiotic therapy should be administered after completing an initial course of 
treatment and securing a clinical response to therapy. Infectious diseases expert 
opinion should be sought. 
Table 2. Guidelines for diagnosis and management of cardiac device infections (Modified 
from Mayo Clinic Guidelines).  
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